Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 2,214 |
| Marketable Securities | 0 | 0 | 19 |
| Receivables | 0 | 0 | 152 |
| Other current assets | 0 | 0 | 451 |
| TOTAL | $0 | $0 | $2,836 |
| Non-Current Assets | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $2,836 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 0 | 0 | 1,043 |
| Accrued Expenses | 0 | 0 | 87 |
| Other current liabilities | 0 | 0 | 501 |
| TOTAL | $0 | $0 | $1,631 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 28 |
| TOTAL | $N/A | $N/A | $28 |
| Total Liabilities | $0 | $0 | $1,659 |
| Shareholders' Equity | |||
| Retained earnings | 0 | 0 | -2,249 |
| Other shareholders' equity | 0 | 0 | 169 |
| TOTAL | $0 | $0 | $1,177 |
| Total Liabilities And Equity | $0 | $0 | $2,836 |